✦ LIBER ✦

Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2-Positive Breast Cancer

✍ Scribed by Roy, V.; Perez, E. A.

Book ID: 126638579
Publisher: Alphamed Press
Year: 2009
Tongue: English
Weight: 92 KB
Volume: 14
Category: Article
ISSN: 1083-7159
DOI: 10.1634/theoncologist.2009-0142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2 therapy. Small molecule HER-2 tyros

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

✍ Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden… 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 324 KB

Beyond trastuzumab: New treatment option

Beyond trastuzumab: New treatment options for HER2-positive breast cancer

✍ Kamal S. Saini; Hatem A. Azim Jr; Otto Metzger-Filho; Sherene Loi; Christos Soti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 126 KB

Trastuzumab beyond progression in HER2-p

Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience

✍ Waddell, T; Kotsori, A; Constantinidou, A; Yousaf, N; Ashley, S; Parton, M; Alle 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB